Form D Explorer

Source evidence

Pierrepont Therapeutics, Inc. · 0002019360-26-000003

D/A filed Sept. 22, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
BROOKLYN
street1
DOWNSTATE TECHNOLOGY CENTER, SUITE 327A
street2
760 PARKSIDE AVENUE
zipCode
11203
entityName
Pierrepont Therapeutics, Inc.
entityType
Corporation
stateOrCountry
NY
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold2409876number2409876/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount5859876number5859876/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment0number0/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count2number2/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: 1e847a9bc8f865b21a5c3d563448e276be33312d3956674172fc08c68d05529d. This proves extraction identity, not the accuracy of the filer's claims.